IL89012A - Peptides eliciting t-cell cytotoxicity against hiv, pharmaceutical compositions containing the same, and kits for detecting hiv infection containing the same - Google Patents

Peptides eliciting t-cell cytotoxicity against hiv, pharmaceutical compositions containing the same, and kits for detecting hiv infection containing the same

Info

Publication number
IL89012A
IL89012A IL89012A IL8901289A IL89012A IL 89012 A IL89012 A IL 89012A IL 89012 A IL89012 A IL 89012A IL 8901289 A IL8901289 A IL 8901289A IL 89012 A IL89012 A IL 89012A
Authority
IL
Israel
Prior art keywords
same
kits
pharmaceutical compositions
cell cytotoxicity
cytotoxicity against
Prior art date
Application number
IL89012A
Other languages
English (en)
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Publication of IL89012A publication Critical patent/IL89012A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL89012A 1988-01-26 1989-01-20 Peptides eliciting t-cell cytotoxicity against hiv, pharmaceutical compositions containing the same, and kits for detecting hiv infection containing the same IL89012A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14869288A 1988-01-26 1988-01-26

Publications (1)

Publication Number Publication Date
IL89012A true IL89012A (en) 1993-07-08

Family

ID=22526912

Family Applications (1)

Application Number Title Priority Date Filing Date
IL89012A IL89012A (en) 1988-01-26 1989-01-20 Peptides eliciting t-cell cytotoxicity against hiv, pharmaceutical compositions containing the same, and kits for detecting hiv infection containing the same

Country Status (8)

Country Link
EP (1) EP0400076B1 (de)
JP (1) JP2569185B2 (de)
AT (1) ATE138077T1 (de)
AU (1) AU621097B2 (de)
CA (1) CA1340907C (de)
DE (1) DE68926499T2 (de)
IL (1) IL89012A (de)
WO (1) WO1989007112A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030449A (en) * 1988-07-21 1991-07-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthetic vaccine against AIDS virus
US5976541A (en) * 1988-01-26 1999-11-02 The United States Of America As Represented By The Department Of Health And Human Services Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope
US5128319A (en) 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
US6210873B1 (en) 1987-08-28 2001-04-03 Board Of Regents, The University Of Texas System Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
US5763160A (en) * 1988-02-12 1998-06-09 United Biomedical, Inc. Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines
EP0339504A3 (de) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Menschliches immunoinsuffizientes Virus (HIV) env-codiertes Peptid, welches im Stande ist, die HIV hemmenden Antikörper bei Säugetieren hervorzurufen
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
US5882853A (en) * 1989-09-01 1999-03-16 The United States Of America As Represented By The Department Of Health And Human Services Method of evaluating HTLV-I-specific T cell responses
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
US6656471B1 (en) 1998-11-17 2003-12-02 Board Of Regents, The University Of Texas System HIV-specific T-cell induction
US7189800B2 (en) 2001-03-27 2007-03-13 Samuel Bogoch Replikin peptides in rapid replication of glioma cells and in influenza epidemics
US7774144B2 (en) 2001-10-26 2010-08-10 Samuel Bogoch System and method for identifying complex patterns of amino acids
US7894999B2 (en) 2001-03-27 2011-02-22 Samuel Bogoch Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds
US7420028B2 (en) 2001-03-27 2008-09-02 Samuel Bogoch Replikins and methods of identifying replikin-containing sequences
EP2348040A1 (de) * 2001-07-09 2011-07-27 Samuel Bogoch Replikin-Peptide und Verwendung davon
US8494781B2 (en) 2003-06-06 2013-07-23 Samuel Bogoch Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
US9254315B2 (en) 2004-04-28 2016-02-09 Samuel Bogoch Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
WO2008140557A2 (en) 2006-10-24 2008-11-20 Samuel Bogoch A method of predicting influenza outbreaks
EP2594578A1 (de) 2007-05-30 2013-05-22 Samuel Bogoch Replikin-Peptide gegen krankheitserregende Infektionen von wirbellosen Tieren in einer Aquakultur
US9233148B2 (en) 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
WO2013013075A2 (en) 2011-07-20 2013-01-24 Samuel Bogoch Peptides shared among lethal cancers and therapeutic compositions comprising said peptides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341620C (en) * 1984-10-18 2011-08-23 Luc Montagnier Envelope antigens of hiv-1
JPS63501716A (ja) * 1985-10-24 1988-07-14 サウスウエスト・ファウンデ−ション・フォア・バイオメディカル・リサ−チ 合成ペプチドおよびａｉｄｓおよびａｒｃの診断ならびにワクチン注射へのその使用
EP0269712A4 (de) * 1986-06-12 1990-06-26 Biogen Nv An der pathogenese einer hiv-infektion beteiligte peptide.
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
AU592258B2 (en) * 1986-12-30 1990-01-04 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins
EP0366718B1 (de) * 1987-05-29 1995-05-10 Tanox Biosystems, Inc. Hiv-1 neutralisierende monoklonale antikörper
IL87391A0 (en) * 1987-08-27 1989-01-31 Repligen Corp Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them

Also Published As

Publication number Publication date
JPH03503166A (ja) 1991-07-18
WO1989007112A1 (en) 1989-08-10
CA1340907C (en) 2000-02-22
EP0400076A1 (de) 1990-12-05
ATE138077T1 (de) 1996-06-15
JP2569185B2 (ja) 1997-01-08
AU621097B2 (en) 1992-03-05
EP0400076A4 (en) 1991-11-13
AU3204489A (en) 1989-08-25
DE68926499T2 (de) 1996-12-19
DE68926499D1 (de) 1996-06-20
EP0400076B1 (de) 1996-05-15

Similar Documents

Publication Publication Date Title
IL89012A (en) Peptides eliciting t-cell cytotoxicity against hiv, pharmaceutical compositions containing the same, and kits for detecting hiv infection containing the same
AU637841B2 (en) Vaccine composition with non-immunosuppressive t-cell epitope component
AU3063389A (en) Hiv-2-type retroviruses of primates, vaccines, diagnostic and pharmaceutical compositions
AU623245B2 (en) Pharmaceutical compositions
GB2213823B (en) Synthetic peptides for use in the diagnosis and prevention of influenza virus infection
AU8172094A (en) Synthetic HTLV-III peptides, compositions and uses thereof
AU1380788A (en) Synthetic peptide antigens for the detection of hiv-1 infection
DK193887A (da) Peptid med bronchodilartorisk og hypotensiv aktivitet
CA2098021A1 (en) Composition Used as a Therapeutic Agent Against Chronic Viral Hepatic Diseases
AU7242796A (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
NZ235316A (en) Vaccine containing capsular polysaccharide conjugated to recombinant c protein of a group b streptococcus, production and use against b streptococcus infection
CA2070647A1 (en) Use of an anticoagulant as a diagnostic agent
DE3869670D1 (de) Latex fuer die immobilisierung von physiologisch aktiven verbindungen und reaktiver latex, der diesen latex verwendet.
AU4246489A (en) New benzoxazolinone derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
ZA904565B (en) Peptides and antibodies derived therefrom for the diagnosis of therapy for and vaccination against htlv-1 infection
RU92004315A (ru) Фармацевтическая композиция, содержащая этопозид
EP0385909A3 (de) Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen
IL81568A0 (en) Plasmids which inhibit human t-cell lymphotropic virus type iii replication
EP0428603A4 (en) Cytotoxic agent against specific virus infection
GR1002576B (el) Φαρμακευτικες συνθεσεις και μια μεθοδος παρασκευης τους.
AU7512287A (en) Expression of human t-cell lymphotropic virus (htlv-iii)reve rse transcriptase and uses thereof
EP0379295A3 (de) Antitryptase-Antikörper und diese enthaltende Zusammensetzung zur Behandlung von AIDS
EP0256385A3 (de) Verwendung von 15-Deoxyspergualin als Arzneimittel
DE3273979D1 (en) 9,10-substituted 2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2h-pyrimido(6,1-a)isoquinolin-4-ones, process for their preparation and their use as medicaments
GB2185478B (en) Novel e-valerolactam, pharmacologically active compositions thereof, processes for the preparation thereof and their medical use

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed